Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-001505
Filing Date
2025-02-25
Accepted
2025-02-25 16:15:46
Documents
108
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K knsa-20241231x10k.htm   iXBRL 10-K 3612000
2 EX-10.22 knsa-20241231xex10d22.htm EX-10.22 88743
3 EX-10.23 knsa-20241231xex10d23.htm EX-10.23 88596
4 EX-10.24 knsa-20241231xex10d24.htm EX-10.24 88576
5 EX-10.25 knsa-20241231xex10d25.htm EX-10.25 57781
6 EX-10.26 knsa-20241231xex10d26.htm EX-10.26 89020
7 EX-10.27 knsa-20241231xex10d27.htm EX-10.27 50614
8 EX-10.40 knsa-20241231xex10d40.htm EX-10.40 22374
9 EX-23.1 knsa-20241231xex23d1.htm EX-23.1 2296
10 EX-31.1 knsa-20241231xex31d1.htm EX-31.1 14130
11 EX-31.2 knsa-20241231xex31d2.htm EX-31.2 14073
12 EX-32.1 knsa-20241231xex32d1.htm EX-32.1 7606
13 EX-32.2 knsa-20241231xex32d2.htm EX-32.2 7520
14 GRAPHIC knsa-20241231x10k006.jpg GRAPHIC 70246
15 GRAPHIC knsa-20241231x10k008.jpg GRAPHIC 67130
  Complete submission text file 0001558370-25-001505.txt   14896187

Data Files

Seq Description Document Type Size
16 EX-101.SCH knsa-20241231.xsd EX-101.SCH 80511
17 EX-101.CAL knsa-20241231_cal.xml EX-101.CAL 82886
18 EX-101.DEF knsa-20241231_def.xml EX-101.DEF 369829
19 EX-101.LAB knsa-20241231_lab.xml EX-101.LAB 725595
20 EX-101.PRE knsa-20241231_pre.xml EX-101.PRE 576426
111 EXTRACTED XBRL INSTANCE DOCUMENT knsa-20241231x10k_htm.xml XML 2678023
Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Filer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38492 | Film No.: 25663435
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)